Net Profit Margin
since 2005
Calculation
Abbott Laboratories, net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net earnings1 | ÷ | Net sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 31.95% | = | 100 | × | 13,402) | ÷ | 41,950) |
| Dec 31, 2023 | 14.27% | = | 100 | × | 5,723) | ÷ | 40,109) |
| Dec 31, 2022 | 15.88% | = | 100 | × | 6,933) | ÷ | 43,653) |
| Dec 31, 2021 | 16.42% | = | 100 | × | 7,071) | ÷ | 43,075) |
| Dec 31, 2020 | 12.99% | = | 100 | × | 4,495) | ÷ | 34,608) |
| Dec 31, 2019 | 11.56% | = | 100 | × | 3,687) | ÷ | 31,904) |
| Dec 31, 2018 | 7.74% | = | 100 | × | 2,368) | ÷ | 30,578) |
| Dec 31, 2017 | 1.74% | = | 100 | × | 477) | ÷ | 27,390) |
| Dec 31, 2016 | 6.71% | = | 100 | × | 1,400) | ÷ | 20,853) |
| Dec 31, 2015 | 21.68% | = | 100 | × | 4,423) | ÷ | 20,405) |
| Dec 31, 2014 | 11.28% | = | 100 | × | 2,284) | ÷ | 20,247) |
| Dec 31, 2013 | 11.79% | = | 100 | × | 2,576) | ÷ | 21,848) |
| Dec 31, 2012 | 14.95% | = | 100 | × | 5,963) | ÷ | 39,874) |
| Dec 31, 2011 | 12.17% | = | 100 | × | 4,728) | ÷ | 38,851) |
| Dec 31, 2010 | 13.15% | = | 100 | × | 4,626) | ÷ | 35,167) |
| Dec 31, 2009 | 18.68% | = | 100 | × | 5,746) | ÷ | 30,765) |
| Dec 31, 2008 | 16.53% | = | 100 | × | 4,881) | ÷ | 29,528) |
| Dec 31, 2007 | 13.92% | = | 100 | × | 3,606) | ÷ | 25,914) |
| Dec 31, 2006 | 7.64% | = | 100 | × | 1,717) | ÷ | 22,476) |
| Dec 31, 2005 | 15.10% | = | 100 | × | 3,372) | ÷ | 22,338) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
The financial data reveals several noteworthy trends in net earnings, net sales, and net profit margin over the analyzed periods.
- Net Earnings
- Net earnings exhibit significant fluctuations across the years. There is an initial decline from 3372 million US$ in 2005 to a low of 1717 million US$ in 2006, followed by a recovery and general upward trend reaching a peak of 7071 million US$ in 2021. Following this high, a slight decrease occurs in 2022 and 2023 before a substantial increase to 13402 million US$ in 2024. The trend indicates periods of volatility but overall growth in profitability towards the end of the cycle.
- Net Sales
- Net sales generally show a positive growth trajectory from 22,338 million US$ in 2005 to 43,653 million US$ in 2022, almost doubling over this span. Some intermittent declines are visible, notably in 2013 and 2014, where sales fall sharply to around 20,000 million US$. After this decline, sales recover and peak in 2022, followed by a slight decrease in the last two years, ending at approximately 41,950 million US$ in 2024. The overall pattern reflects steady expansion with occasional contractions.
- Net Profit Margin
- The net profit margin percentage shows considerable variability, fluctuating between a low of 1.74% in 2017 and a high of 31.95% in 2024. Early years show margins in the range of 7.64% to 18.68%, indicating moderate profitability. Notably, there is a marked dip in profitability around 2016-2017, followed by a resurgence starting in 2018, culminating in a significant margin improvement in 2024. This suggests increasing efficiency or a more profitable product/service mix in the later years.
In summary, the financial performance metrics indicate a company experiencing cyclical revenue and earnings changes but demonstrating resilience and growth over the long term. The significant improvement in net profit margin towards the latest year implies enhanced operational effectiveness or strategic shifts yielding higher profitability.
Comparison to Competitors
Abbott Laboratories, net profit margin, long-term trends, comparison to competitors
| Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2024 | 31.95% | 1.24% | 3.41% | 27.81% | 11.36% | 3.65% |
| Dec 31, 2023 | 14.27% | 2.34% | 3.52% | 25.24% | 12.03% | 6.09% |
| Dec 31, 2022 | 15.88% | 1.29% | 3.87% | 21.25% | 15.90% | 6.25% |
| Dec 31, 2021 | 16.42% | 2.72% | 4.46% | 29.85% | 11.97% | 6.06% |
| Dec 31, 2020 | 12.99% | 2.68% | 3.78% | 24.33% | 16.56% | 6.03% |
| Dec 31, 2019 | 11.56% | 2.59% | 4.66% | 30.80% | 15.16% | 5.76% |
| Dec 31, 2018 | 7.74% | -0.31% | 4.11% | 30.29% | 10.36% | 5.33% |
| Dec 31, 2017 | 1.74% | 3.58% | 4.31% | 21.09% | 13.56% | 5.28% |
| Dec 31, 2016 | 6.71% | 3.00% | 2.93% | 27.21% | 12.27% | 3.81% |
| Dec 31, 2015 | 21.68% | 3.42% | 3.27% | 24.69% | 13.20% | 3.72% |
| Dec 31, 2014 | 11.28% | 3.33% | 3.52% | 19.65% | 18.02% | 4.33% |
| Dec 31, 2013 | 11.79% | 3.62% | 3.55% | 29.62% | 20.90% | 4.62% |
| Dec 31, 2012 | 14.95% | 3.15% | 4.37% | 30.14% | 22.35% | 5.03% |
| Dec 31, 2011 | 12.17% | 3.23% | 4.42% | 28.17% | 19.43% | 5.08% |
| Dec 31, 2010 | 13.15% | 3.55% | 4.99% | 27.02% | 19.59% | 4.95% |
| Dec 31, 2009 | 18.68% | 3.74% | 7.80% | 22.11% | 14.86% | 4.42% |
| Dec 31, 2008 | 16.53% | 3.67% | 4.04% | 23.35% | 16.51% | 3.70% |
| Dec 31, 2007 | 13.92% | 3.45% | 5.56% | 24.06% | 22.78% | 6.26% |
| Dec 31, 2006 | 7.64% | 3.12% | 5.52% | 19.33% | 22.55% | 5.89% |
| Dec 31, 2005 | 15.10% | 3.31% | 5.53% | 41.41% | 17.94% | 7.36% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Abbott Laboratories, net profit margin, long-term trends, comparison to sector (health care equipment & services)
| Abbott Laboratories | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2024 | 31.95% | 4.34% |
| Dec 31, 2023 | 14.27% | 4.93% |
| Dec 31, 2022 | 15.88% | 4.95% |
| Dec 31, 2021 | 16.42% | 5.52% |
| Dec 31, 2020 | 12.99% | 5.26% |
| Dec 31, 2019 | 11.56% | 5.25% |
| Dec 31, 2018 | 7.74% | 3.79% |
| Dec 31, 2017 | 1.74% | 4.90% |
| Dec 31, 2016 | 6.71% | 4.11% |
| Dec 31, 2015 | 21.68% | 4.94% |
| Dec 31, 2014 | 11.28% | 4.88% |
| Dec 31, 2013 | 11.79% | 5.40% |
| Dec 31, 2012 | 14.95% | 6.33% |
| Dec 31, 2011 | 12.17% | 6.03% |
| Dec 31, 2010 | 13.15% | 6.35% |
| Dec 31, 2009 | 18.68% | 6.98% |
| Dec 31, 2008 | 16.53% | 5.85% |
| Dec 31, 2007 | 13.92% | 6.89% |
| Dec 31, 2006 | 7.64% | 6.33% |
| Dec 31, 2005 | 15.10% | 7.71% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Abbott Laboratories, net profit margin, long-term trends, comparison to industry (health care)
| Abbott Laboratories | Health Care | |
|---|---|---|
| Dec 31, 2024 | 31.95% | 7.02% |
| Dec 31, 2023 | 14.27% | 9.24% |
| Dec 31, 2022 | 15.88% | 11.62% |
| Dec 31, 2021 | 16.42% | 12.42% |
| Dec 31, 2020 | 12.99% | 8.45% |
| Dec 31, 2019 | 11.56% | 11.58% |
| Dec 31, 2018 | 7.74% | 9.92% |
| Dec 31, 2017 | 1.74% | 8.05% |
| Dec 31, 2016 | 6.71% | 10.68% |
| Dec 31, 2015 | 21.68% | 11.77% |
| Dec 31, 2014 | 11.28% | 12.15% |
| Dec 31, 2013 | 11.79% | 12.81% |
| Dec 31, 2012 | 14.95% | 11.86% |
| Dec 31, 2011 | 12.17% | 10.50% |
| Dec 31, 2010 | 13.15% | 10.48% |
| Dec 31, 2009 | 18.68% | 15.08% |
| Dec 31, 2008 | 16.53% | 11.35% |
| Dec 31, 2007 | 13.92% | 11.02% |
| Dec 31, 2006 | 7.64% | 13.95% |
| Dec 31, 2005 | 15.10% | 13.38% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).